Depot neuroleptics: the relevance of psychosocial factors--a United States perspective
- PMID: 6143746
Depot neuroleptics: the relevance of psychosocial factors--a United States perspective
Abstract
The need for psychosocial strategies in the treatment of schizophrenic patients after discharge is discussed in terms of relapse rates associated with maintenance neuroleptic therapy in the United States and elsewhere. The history of drug and psychosocial treatment is reviewed, and the rationale of psychosocial treatment is explained. New psychosocial approaches are explored, including the "expressed emotion" concept, the possible influence of environmental stress conditions, and the use of family therapy and social skills training to lower relapse rates.
Similar articles
-
The use of depot neuroleptics: clinical experience in the United States.J Clin Psychiatry. 1984 May;45(5 Pt 2):5-12. J Clin Psychiatry. 1984. PMID: 6370987 Review.
-
Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom.J Clin Psychiatry. 1984 May;45(5 Pt 2):43-9. J Clin Psychiatry. 1984. PMID: 6143747 Clinical Trial.
-
Antipsychotic medication: clinical guidelines for maintenance therapy.J Clin Psychiatry. 1985 May;46(5 Pt 2):6-15. J Clin Psychiatry. 1985. PMID: 2859281 Review.
-
Relapse prevention and recovery in the treatment of schizophrenia.J Clin Psychiatry. 2006;67 Suppl 5:19-23. J Clin Psychiatry. 2006. PMID: 16822093
-
Outpatient treatment: community and private practice support systems.J Clin Psychiatry. 1983 Jun;44(6 Pt 2):15-22. J Clin Psychiatry. 1983. PMID: 6133852
Cited by
-
Modelling the treated course of schizophrenia: development of a discrete event simulation model.Pharmacoeconomics. 2005;23 Suppl 1:17-33. doi: 10.2165/00019053-200523001-00003. Pharmacoeconomics. 2005. PMID: 16416759
-
Will the new antipsychotics improve the treatment of schizophrenia?BMJ. 1993 Sep 25;307(6907):749-50. doi: 10.1136/bmj.307.6907.749-a. BMJ. 1993. PMID: 8106051 Free PMC article. No abstract available.
-
Pharmacological treatment of patients with schizophrenia. Past and present problems and potential future therapy.Drugs. 1990 Apr;39(4):481-8. doi: 10.2165/00003495-199039040-00001. Drugs. 1990. PMID: 2190791 Review. No abstract available.
-
A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.BMC Health Serv Res. 2009 Feb 18;9:32. doi: 10.1186/1472-6963-9-32. BMC Health Serv Res. 2009. PMID: 19226465 Free PMC article.
-
Low dose maintenance medication for schizophrenia.Br Med J (Clin Res Ed). 1986 Aug 30;293(6546):515-6. doi: 10.1136/bmj.293.6546.515. Br Med J (Clin Res Ed). 1986. PMID: 2875757 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical